The phase 3 BROADWAY clinical trial (NCT05142722) was designed to evaluate 10 mg Obicetrapib in adult patients with ... TANDEM evaluated Obicetrapib as part of a FDC tablet with ezetimibe, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback